Myocardial Perfusion Study to Detect Coronary Microvascular Abnormality in Diabetic Patients With Nonfatal Myocardial Infarction

State University of New York - Upstate Medical University100 enrolled

Overview

The goal of this study is to use MCE (myocardial contrast/perfusion echocardiography) to study and compare short/long term change of myocardial perfusion abnormality and cardiac outcome in diabetic patients after nonfatal MI (heart attack), who are treated with different glucose control agents.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Myocardial Infarction

Eligibility

Sex: ALLMin age: 18 YearsMax age: 71 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic and nondiabetic patients will be initially recruited and studied after acute nonfatal MI and revascularization with either PCI or CABG Exclusion Criteria: * Patients are excluded if they are older than 70 year old, require mechanical ventilation, are receiving intravenous pressors or hemodynamic support, or if the motion of segments associated with infarct-related artery can not be accurately determined.

Locations (1)

SUNY Upstate Medical University

Syracuse, New York, United States

Outcomes

Primary Outcomes

Perfusion abnormalities in nondiabetic and diabetic patients

Time frame: short term (3 month) and long term (12 month).

Secondary Outcomes

The effect of different glycemic control strategies on the reduction of coronary injury in diabetic and non-diabetic subjects

Time frame: short term (3 month) and long term (12 month)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.